NCT07648355
Visual and Patient Reported Outcomes With Clareon TruPlus
Recruiting
Not specifiedAges 18+ObservationalOVO LASIK + LensInvestigator-initiated
~40 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Clareon TruPlus
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Binocular photopic DCIVA
Measured over 3 months postoperatively
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Martha Whiting, MD · PRINCIPAL_INVESTIGATOR · OVO Lasik and Lens LLC
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Willing and able to understand and sign informed consent.
Adult patients (\>40 years old) undergoing age-related cataract surgery with expected best-corrected visual outcomes of 20/25 or better in both eyes pre-operatively as determined by surgeon and with regular corneal astigmatism correctable to less than 0.75 diopters post-operatively with no more than a T6 toric power IOL.
Normal ocular findings aside from cataract and mild dry eye.
Exclusion
Subjects targeted for monovision.
Moderate-severe corneal pathology, irregular astigmatism, preexisting macular disease and other retinal degenerative diseases, diabetic retinopathy that is expected to cause future vision loss, glaucoma, severe dry eye disease, nystagmus, strabismus, amblyopia, zonular laxity or dehiscence, pseudoexfoliation.
Previous history of any ocular surgery including LASIK (excluding minor lid procedures).
Patients with irregular astigmatism/topography, corneal dystrophies, and pupil abnormalities.
Participation in another clinical study that could interfere with the results.
Any active ocular infection or inflammation.
What this trial measures
- Binocular photopic DCIVA3 months postoperatively
Measured using a standardized ETDRS chart at 66cm.